1. Apoptosis, Up the Ante Cancer Cell
Palaniraja Thandapani, Iannis Aifantis 
Cancer Cell 
Volume 32, Issue 4, Pages (October 2017)
DOI: /j.ccell
Copyright © Terms and Conditions

2. Figure 1
AML Combinatorial Therapy Using BAX Activators and BH3 Mimetics
Overexpression of pro-survival BCL-2 proteins in cancers inhibits apoptosis by suppressing pro-apoptotic BAX/BAK. BH3 mimetics like venetoclax and navitoclax release BAX/BAK by neutralizing pro-survival BCL-2 members and sensitize cells to apoptosis. Direct BAX activators like BTSA1 can directly activate BAX and induce cell death synergistically with BH3 mimetics like venetoclax.
Cancer Cell  , DOI: ( /j.ccell )
Copyright © Terms and Conditions